Tom L. Churchwell
Directeur Général chez Vimedicus, Inc.
Provenance du réseau au premier degré de Tom L. Churchwell
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
Illinois Biotechnology Industry Organization
 Illinois Biotechnology Industry Organization Miscellaneous Commercial ServicesCommercial Services Illinois Biotechnology Industry Organization, also known as ibio, is a state trade association representing the life sciences industry in Illinois. The non-profit company is based in Chicago, IL. The organization's mission is to promote, connect, and engage the life sciences community to drive discovery, transform lives through groundbreaking research, and grow the economy. The company's membership ranges from corporations to startup companies in the biopharma, medical device, and nutrition industries. The Illinois life sciences industry is recognized as a national leader, and ibio's members are committed to expanding the boundaries of science by discovering, developing, and delivering innovative and needed therapeutics and products to transform patients' lives.
34
| Non-Profit Organization | Miscellaneous Commercial Services | 34 |
zuChem, Inc.
 zuChem, Inc. Wholesale DistributorsDistribution Services zuChem, Inc. manufactures and supplies glycochemicals for the pharmaceutical, food and related industries. Its products include natural polyols, rare sugars and carbohydrates. Its glycochemicals are key components of many drugs and drug candidates as well as many specialty food ingredients. The company was founded by David C. Demirjian in 2001 and is headquartered in Chicago, IL.
8
| Holding Company | Wholesale Distributors | 8 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Tom L. Churchwell via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Illinois Biotechnology Innovation Organization | Director/Board Member Director/Board Member Director/Board Member | ||
Astellas Pharma US, Inc.
 Astellas Pharma US, Inc. Pharmaceuticals: MajorHealth Technology Astellas Pharma US, Inc. manufactures pharmaceutical products. It offers cardiology, dermatology, immunology, infectious diseases, and urology. The firm was founded in 2005 and is headquartered in Northbrook, IL. | Pharmaceuticals: Major | Corporate Officer/Principal President | |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America Pharmaceuticals: MajorHealth Technology Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital LLC (Agent Capital) is a venture capital firm founded in 2017 by Geeta Vemuri. The firm is headquartered in Waltham, Massachusetts. | Investment Managers | Consultant / Advisor Founder | |
MediChem Life Sciences, Inc.
 MediChem Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Part of DGI Resolution, Inc., MediChem Life Sciences, Inc. provides research and drug discovery services. The company is based in Woodridge, IL. The company was founded in 1987 by Michael T. Flavin. MediChem Life Sciences was acquired by deCODE genetics, Inc. on March 18, 2002 for $52.85 million. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Baxter Ventures
 Baxter Ventures Investment ManagersFinance Baxter Ventures (Baxter Ventures) is a venture capital firm subsidiary of Baxter International, Inc. founded in 2011. The firm is headquartered in Deerfield, Illinois. | Investment Managers | Corporate Officer/Principal Chief Executive Officer | |
| The University of Chicago | College/University | Doctorate Degree Masters Business Admin | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree | |
Chromatin, Inc.
 Chromatin, Inc. BiotechnologyHealth Technology Chromatin, Inc. provides seed and feedstock products for traditional agriculture and bio-industrial processes. The firm markets seed products under its Sorghum Partners brand, primarily the grain sorghum and forage sorghum seed types. It also delivers sorghum products for companies seeking renewable feedstock. Its service areas encompass supplying seed, contracting growers, providing agronomic support, and overseeing harvest and delivery of feedstock in the form and specifications required by bio-processors. The company was founded by Kevin Keith, Daphne Preuss and Gregory Paul Copenhaver in 2001 and is headquartered in Chicago, IL. | Biotechnology | Founder Corporate Secretary | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Genencor International, Inc.
 Genencor International, Inc. BiotechnologyHealth Technology Genencor International, Inc. develops and manufactures enzyme product solutions for industrial, agricultural and health care markets. It finds genes and alters their proteins for use in cleaning, textile, health care, food and animal feed products using gene discovery, molecular evolution, functional genomics and immunology techniques. The company also develops solutions for the biofuels, biodefense and biosafety industries. Genencor International was founded in 1982 and is located in Rochester, NY. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| BAXTER INTERNATIONAL INC. | Medical Specialties | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| APTINYX | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| DePaul University | College/University | Masters Business Admin Masters Business Admin | |
| University of Illinois | College/University | Undergraduate Degree Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree Masters Business Admin | |
Cempra Pharmaceuticals, Inc.
 Cempra Pharmaceuticals, Inc. BiotechnologyHealth Technology Cempra Pharmaceuticals, Inc. develops medicines for treating drug-resistant bacterial infections. The firm's antibacterial products, both in clinical trials, address the urgent and increasing need for new treatments targeting drug-resistant bacterial infections in both the hospital and the community. The company was founded by Prabhavathi B. Fernandes IN 2006 and is headquartered in Chapel Hill, NC. | Biotechnology | Director/Board Member | |
| NUPATHE INC | Medical Specialties | Director/Board Member | |
| TENGION, INC. | Biotechnology | Director/Board Member | |
| Southeast BIO | Director/Board Member | ||
Citigroup Global Markets Holdings, Inc.
 Citigroup Global Markets Holdings, Inc. Investment Banks/BrokersFinance Citigroup Global Markets Holdings, Inc. provides investment banking and securities brokerage services. It offers financial advisory, research and capital raising services to corporations, governments and individuals. The company was founded in 1977 and is headquartered in New York, NY. | Investment Banks/Brokers | Corporate Officer/Principal | |
Carbon Biosciences, Inc.
 Carbon Biosciences, Inc. Medical/Nursing ServicesHealth Services Carbon Biosciences, Inc. is a biotech company that is based in Boston, MA. The company is focused on expanding the therapeutic potential of gene therapy through its proprietary platform which leverages novel parvoviruses that have been pressure tested by nature to target specific tissues and carry a larger cargo with minimal neutralizing immunity and the potential to re-dose. The company is working to expand the gene therapy toolbox for the treatment of the world's most devastating and difficult to treat diseases. Carbon was founded by Longwood Fund and gene therapy pioneers, John F. Engelhardt, Ph.D., and Robert M. Kotin, Ph.D. | Medical/Nursing Services | Director/Board Member | |
Gliknik, Inc.
 Gliknik, Inc. Pharmaceuticals: MajorHealth Technology Gliknik, Inc. discovers and develops biotechnology drugs for autoimmune diseases and cancer. The company was founded by David S. Block and Scott E. Strome in 2007 and is headquartered in Baltimore, MD. | Pharmaceuticals: Major | Director/Board Member | |
ViTToria Biotherapeutics, Inc.
 ViTToria Biotherapeutics, Inc. BiotechnologyHealth Technology viTToria Biotherapeutics, Inc. is a gene-edited cell therapeutics company based in Philadelphia, PA. The company is developing novel CAR-T cell therapies using their proprietary Senza5 platform, which maximizes stemness, durability, and target cell cytotoxicity. The technology is exclusively licensed from the University of Pennsylvania and has pipeline applications in oncology and autoimmune diseases. The company was founded by Bruce A. Peacock and Nicholas Siciliano, with Nicholas Siciliano serving as CEO since incorporation. | Biotechnology | Director/Board Member | |
Immunitas Therapeutics, Inc.
 Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Immunitas Therapeutics, Inc. provides cancer therapeutics services. The company was founded by Lea Hachigian, Kai Wucherpfennig, K. Dane Wittrup and Mario Suv? and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
| Central University of Haryana | College/University | Graduate Degree | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Director/Board Member | |
Syntimmune, Inc.
 Syntimmune, Inc. BiotechnologyHealth Technology Syntimmune, Inc. engages in the research and development of therapeutics for autoimmune diseases based on neonatal Fc receptor biology. Its pipeline include SYNT001 which has target indication for dermatology, hematology, and neurology. It also focuses on pre-clinical investigation of SYTN002 and related compounds such as peptide mimetics. The company was founded by Laurence J. Blumberg and Richard S. Blumberg in 2013 and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
Gadeta BV
 Gadeta BV Medical SpecialtiesHealth Technology Gadeta BV discovers and develops novel cancer immunotherapies. It provides groundbreaking discoveries regarding the role of cell receptors in the broad of heamatological and solid tumor cells. The firm develops t-cells engineered to express a defined gamma delta, an anti- cancer product that eradicates tumors. The company was founded by Jurgen Kuball in 2015 and is headquartered in Utrecht, Netherlands. | Medical Specialties | Director/Board Member | |
True North Therapeutics, Inc.
 True North Therapeutics, Inc. BiotechnologyHealth Technology True North Therapeutics, Inc. operates as a biopharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class product candidates for complement-mediated diseases. The company was founded by Nancy E. Stagliano in 2013 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
Corridor Pharmaceuticals, Inc.
 Corridor Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Corridor Pharmaceuticals, Inc. develops and manufactures biopharmaceutical products. The company was founded on February 1, 2008 and is headquartered in Lutherville, MD | Pharmaceuticals: Major | Director/Board Member | |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member | |
Fresenius Kabi Pharmaceuticals Holding, Inc. (United States)
 Fresenius Kabi Pharmaceuticals Holding, Inc. (United States) Pharmaceuticals: MajorHealth Technology Part of Fresenius SE & Co. KGaA, Fresenius Kabi Pharmaceuticals Holding, Inc. is a pharmaceutical company based in Wilmington, DE. The company develops pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ARCH Development Partners LLC
 ARCH Development Partners LLC Investment ManagersFinance ARCH Development Partners LLC is an Independent Venture Capital firm founded in 2001. The firm is headquartered in Chicago. | Investment Managers | Corporate Officer/Principal | |
| Illinois Wesleyan University | College/University | Undergraduate Degree | |
| Bradley University | College/University | Masters Business Admin | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LIGAND PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Virginia | College/University | Doctorate Degree | |
| Virginia Polytechnic Institute & State University | College/University | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 48 |
| Inde | 2 |
| Pays-Bas | 2 |
| Irlande | 2 |
Sectorielle
| Health Technology | 27 |
| Consumer Services | 11 |
| Finance | 9 |
| Commercial Services | 3 |
| Process Industries | 2 |
Opérationnelle
| Director/Board Member | 146 |
| Corporate Officer/Principal | 63 |
| President | 25 |
| Chairman | 23 |
| Independent Dir/Board Member | 23 |
Relations les plus connectées
| Insiders | |
|---|---|
| Timothy Walbert | 40 |
| Geeta S. Vemuri | 33 |
| Norbert Riedel | 29 |
| Alan L. Heller | 23 |
| K'Lynne Johnson | 17 |
| Percival Barretto-Ko | 15 |
| Edward Fiorentino | 12 |
| Henrique Ubrig | 12 |
| Ashish Khanna | 10 |
| Nelson L. Levy | 9 |
| Daniel Brennan | 9 |
| Steven E. Ducommun | 7 |
| Arthur L. Holden | 6 |
| Douglas S. Stewart | 6 |
| Rajni Aneja | 6 |
- Bourse
- Insiders
- Tom L. Churchwell
- Connexions Sociétés
